XTL Biopharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
XTL Biopharmaceuticals has a total shareholder equity of $2.2M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $2.4M and $206.0K respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$2.01m |
Equity | US$2.22m |
Total liabilities | US$206.00k |
Total assets | US$2.43m |
Financial Position Analysis
Short Term Liabilities: XTLB's short term assets ($2.0M) exceed its short term liabilities ($206.0K).
Long Term Liabilities: XTLB has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: XTLB is debt free.
Reducing Debt: XTLB has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: XTLB has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: XTLB has sufficient cash runway for 2.3 years if free cash flow continues to grow at historical rates of 3% each year.